[Summary] Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Explained

Global Cancer Statistics 2018: A Comprehensive Overview

Context

Understanding the global burden of cancer is a critical prerequisite for developing effective public health strategies and allocating resources judiciously. Cancer remains a leading cause of morbidity and mortality worldwide, yet comprehensive, up-to-date statistics on its incidence (new cases) and mortality (deaths) are often fragmented or unavailable, particularly in low- and middle-income countries. This significant data gap impedes evidence-based policy-making, hinders the identification of regional disparities, and ultimately undermines efforts to mitigate the disease's devastating impact. The paper addresses this pressing need by providing a detailed, global status report on cancer, offering a foundational dataset for researchers, policymakers, and healthcare providers to confront this complex public health challenge.

The accurate estimation of cancer incidence and mortality is not merely an academic exercise; it forms the bedrock for planning and implementing targeted cancer control programs. Without reliable data, countries struggle to prioritize interventions, assess the effectiveness of existing programs, or even understand the unique cancer profiles affecting their populations. This work, therefore, is indispensable for illuminating the varying patterns of cancer across diverse geographic and economic landscapes, thereby enabling a more precise and equitable global response to the disease.

Key Contributions

• The paper presents comprehensive GLOBOCAN 2018 estimates, detailing cancer incidence and mortality across 36 cancer types in 185 countries, offering a vital global snapshot.
• It highlights significant geographic variability in cancer patterns, demonstrating how incidence and mortality rates differ substantially across 20 world regions and varying levels of economic development.
• Researchers show that lung cancer was the most commonly diagnosed cancer and the leading cause of cancer death globally in 2018, while also identifying sex-specific and regional variations in cancer burden.
• The study underscores the critical importance of high-quality cancer registry data for evidence-based cancer control, noting its scarcity in many low- and middle-income countries.
• It emphasizes the role of the Global Initiative for Cancer Registry Development (GICR) as an international partnership dedicated to improving data collection and utilization for national cancer control efforts.

Method (Simple Explanation)

The core methodology employed in this study centers on generating the GLOBOCAN 2018 estimates, a sophisticated process designed to provide comprehensive cancer statistics even in regions with limited direct data. This approach primarily leverages data from population-based cancer registries (PBCRs), which systematically collect information on all new cancer cases within a defined population. For countries possessing high-quality PBCR data, these direct observations form the basis of the estimates.

To address the challenge of incomplete or absent PBCR data in many parts of the world, particularly in low- and middle-income countries, the authors employ a suite of statistical modeling and estimation techniques. This often involves extrapolating from data available in neighboring countries with similar demographic and epidemiological profiles, or utilizing national mortality data in conjunction with estimated mortality-to-incidence ratios (MIRs) derived from regions with robust registry data. The process also incorporates age-standardization, a crucial step that adjusts for differences in age structures between populations, thereby allowing for meaningful comparisons of cancer rates across diverse regions and over time. This meticulous approach ensures that, despite data limitations, the GLOBOCAN estimates offer the most reliable possible picture of the global cancer burden.

Results

• Globally, an estimated 18.1 million new cancer cases and 9.6 million cancer deaths occurred in 2018, with non-melanoma skin cancer accounting for a notable portion of incidence (Figure 1).
• Lung cancer emerged as the most frequently diagnosed cancer and the leading cause of cancer death for both sexes combined, closely followed by female breast cancer for incidence and colorectal cancer for mortality (Table 1, Figure 2).
• Cancer patterns exhibited significant sex-specific differences; among males, lung cancer was most common, while breast cancer predominated among females for both incidence and mortality (Figure 2).
• The study revealed pronounced geographic variability, with Asia bearing the largest proportion of the global cancer burden (48.4% of cases and 57.3% of deaths), and distinct cancer profiles observed across different world regions based on economic development (Table 1, Figure 3).
• Cervical cancer, though ranking fourth for both incidence and mortality among females globally, showed particularly high rates in sub-Saharan Africa, highlighting regional disparities (Figure 2, Figure 4).

Applications

• These global cancer statistics provide an essential foundation for national health ministries and policymakers to develop and refine evidence-based cancer control programs, ensuring resources are directed towards the most pressing cancer burdens in their populations.
• The detailed estimates serve as a critical resource for epidemiological researchers, enabling them to investigate trends, identify risk factors, and explore disparities in cancer incidence and mortality across diverse geographic and socioeconomic contexts.
• The data facilitates the identification of regions with significant data gaps, thereby guiding international partnerships and initiatives, such as the Global Initiative for Cancer Registry Development, to strengthen cancer surveillance systems worldwide.
• The comprehensive overview supports public health campaigns and educational efforts by highlighting the most prevalent and deadly cancers, allowing for targeted prevention strategies and improved public awareness.

Why it Matters

This paper delivers an indispensable snapshot of the global cancer landscape in 2018, serving as a foundational resource for public health professionals, policymakers, and researchers alike. Its detailed estimates not only quantify the immense human toll of cancer but also illuminate the profound geographic and socioeconomic disparities that shape its burden. By meticulously compiling and analyzing data from diverse sources, the study underscores the dynamic interplay between economic development, lifestyle factors, and cancer epidemiology, providing crucial insights into how these elements contribute to varying cancer profiles across the globe.

Moreover, the work critically highlights the persistent challenges in data collection, particularly in low- and middle-income countries, where the need for accurate statistics is often greatest. This emphasis on data quality and availability is a powerful call to action, galvanizing efforts to strengthen cancer surveillance systems worldwide. Ultimately, the insights derived from such comprehensive analyses are vital for shaping future research agendas, fostering innovative approaches to cancer prevention and treatment, and ensuring that global cancer control strategies are both equitable and effective in confronting one of humanity's most formidable health challenges.

Using SpatialRead to Understand This Paper

• SpatialRead enables readers to highlight dense paragraphs or complex concepts, such as the detailed methodology for estimating cancer incidence and mortality, and engage in focused AI conversations for deeper understanding.
• Understanding the nuanced geographic variability presented in figures like Figure 3 and Figure 4 becomes clearer as the tool allows users to capture these visual elements and query AI for explanations of specific patterns or trends.
• The tool provides access to multiple AI models (OpenAI, Perplexity, Gemini, Anthropic) for nuanced explanations tailored to different learning styles, which is particularly helpful when interpreting the various statistical estimation techniques described.
• Grasping the implications of large datasets presented in tables, such as Table 1 detailing global cancer incidence and mortality, is simplified by SpatialRead's ability to extract and explain specific data points or comparisons.
• The screenshot feature allows capturing figures, diagrams, tables, and formulae directly from the PDF, then querying AI about these visual elements for clearer comprehension of the global cancer statistics and their regional breakdowns.
• SpatialRead can help clarify the distinctions between incidence and mortality rates, and how they are calculated or estimated for different cancer types and countries, ensuring a precise understanding of the paper's core findings.

Download SpatialRead →

Open access PDF →